Oaktree Acquisition Corp III Life Sciences Unit
OACCU
6 hedge funds and large institutions have $9.54M invested in Oaktree Acquisition Corp III Life Sciences Unit in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.
9.44% less ownership
Funds ownership: 14.41% → 4.97% (-9.4%)
45% less funds holding
Funds holding: 11 → 6 (-5)
68% less capital invested
Capital invested by funds: $29.7M → $9.54M (-$20.2M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$206K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.53M |
| 2 |
MCM
Moore Capital Management
New York
|
-$5.45M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.84M |
| 4 |
LIP
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
|
-$3.13M |
| 5 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$2.61M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
ADAR1 Capital Management
Austin,
Texas
| $5.48M | – | – | – |
|
|
AAA
2
Affinity Asset Advisors
New York
| $2.65M | – | – | – |
|
3
Citigroup
New York
| $550K | – | – | – |
|
|
AC
4
Athos Capital
Hong Kong
| $531K | – | – | – |
|
|
CS
5
Clear Street
New York
| $221K | +$206K | +19,588 | +1,590% |
|
|
6
UBS Group
Zurich,
Switzerland
| $104K | +$3.16K | +300 | +3% |
|
|
7
Millennium Management
New York
| – | -$5.53M | -529,858 | Closed |
|
|
MCM
8
Moore Capital Management
New York
| – | -$5.45M | -525,000 | Closed |
|
|
SSA
9
Schonfeld Strategic Advisors
New York
| – | -$3.84M | -367,622 | Closed |
|
|
LIP
10
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
| – | -$3.13M | -300,000 | Closed |
|
|
WA
11
Whitebox Advisors
Minneapolis,
Minnesota
| – | -$2.61M | -250,000 | Closed |
|
OACCU Hedge Fund Activity: Q2 2025 in Review
6 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Unit (OACCU) for Q2 2025, worth a combined $9.54M — down 68% from $29.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of OACCU and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Clear Street, adding an estimated $206K. The largest seller was Millennium Management, exiting entirely with an estimated $5.53M sold.
- 6 institutional investors held Oaktree Acquisition Corp III Life Sciences Unit (OACCU) as of Q2 2025, down from 11 in Q1 2025.
- Funds reported $9.54M of Oaktree Acquisition Corp III Life Sciences Unit stock for Q2 2025, down 68% quarter-over-quarter.
- 0 funds opened new Oaktree Acquisition Corp III Life Sciences Unit positions in Q2 2025 and 5 closed out, a net change of -5 holders.
- The largest Oaktree Acquisition Corp III Life Sciences Unit buyer in Q2 2025 was Clear Street, an estimated $206K added.
- The largest Oaktree Acquisition Corp III Life Sciences Unit seller in Q2 2025 was Millennium Management, an estimated $5.53M sold.
Based on aggregated 13F filings for Q2 2025.